Down-regulated DEGs in recGBM included genes involved in cell proliferation (EGFR), possibly brain tumor cell growth (BCAN), deadenylation of mRNA, which is linked to neurodevelopmental disorders (CNOT2), and multi-drug resistance (ABCG2). This evidence concerns the gene BCAN and brain neoplasm.